Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-087227·CITIUS ONCOLOGY, INC.
Schedule 13D ownership disclosure
CITIUS ONCOLOGY INC
Common Shares, $0.0001 par value per share · CUSIP: 17331Y109
Event date: 2025-09-10
- Filing-level shares
- 66,049,615.00
- Percent of class
- 79.1%
- Citius Pharmaceuticals, Inc.Reported CIK 0001506251
Shares: 66,049,615.00 · Class: 79.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-087227
- Form type
- SCHEDULE 13D/A
- Filer
- CITIUS ONCOLOGY, INC.
- CIK
- CIK 1851484
- Filed
- Sep 12, 2025
- Reporting period
- Sep 10, 2025
- Description
- Schedule 13D beneficial ownership